A Study to Evaluate the Educational Needs of Patients with Dexamethasone-Induced Hiccups


About this study

The purpose of this study is to provide descriptive data on hiccup incidence among a group of patients at risk, to provide descriptive data on the percentage of patients who choose to engage in a short educational session on hiccups, and to provide descriptive data on whether patients reported finding this educational session helpful.




Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • English-speaking patient (aged 18 or older).
  • Has received dexamethasone either intravenously or as a prescription in the past 2 weeks. 
  • Patients do not have to be experiencing hiccups at the time of contact, but it is anticipated that these patients will likely have recurrent symptoms based on further or episodic dexamethasone treatment. 
  • Patients must currently be in an outpatient setting, as it is unlikely that an educational session would be relevant or of value to an inpatient.

Exclusion Criteria:

  • Individuals under 18 years of age.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Aminah Jatoi, M.D.

Open for enrollment

Contact information:

Kathryn Cook B.S.

(507) 422-5154


More information


Publications are currently not available

Mayo Clinic Footer